Vaia Vlamis

5.6k total citations · 1 hit paper
36 papers, 4.1k citations indexed

About

Vaia Vlamis is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Vaia Vlamis has authored 36 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Surgery, 16 papers in Pulmonary and Respiratory Medicine and 12 papers in Neurology. Recurrent topics in Vaia Vlamis's work include Testicular diseases and treatments (14 papers), Neuroblastoma Research and Treatments (12 papers) and Sarcoma Diagnosis and Treatment (6 papers). Vaia Vlamis is often cited by papers focused on Testicular diseases and treatments (14 papers), Neuroblastoma Research and Treatments (12 papers) and Sarcoma Diagnosis and Treatment (6 papers). Vaia Vlamis collaborates with scholars based in United States, Sweden and Spain. Vaia Vlamis's co-authors include Robert J. Motzer, Madhu Mazumdar, Dean F. Bajorin, George J. Bosl, Glenn Heller, William J. Hoskins, Paul A. Meyers, Ralph C. Marcove, John H. Healey and Gerald Rosen and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Vaia Vlamis

36 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.

1992 563 citations Glenn Heller, Vaia Vlamis et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vaia Vlamis United States	28	1.8k	1.6k	1.0k	750	578	36	4.1k
Eva Cavallin‐Ståhl Sweden	39	1.6k 0.9×	1.0k 0.6×	1.3k 1.2×	817 1.1×	584 1.0×	119	4.6k
Andrea Hayes‐Jordan United States	33	1.5k 0.9×	2.0k 1.3×	1.2k 1.1×	619 0.8×	222 0.4×	123	3.8k
Sophie D. Fosså Norway	30	1.5k 0.9×	973 0.6×	739 0.7×	604 0.8×	326 0.6×	81	3.0k
Michele Bisceglia Italy	40	1.5k 0.8×	1.1k 0.7×	764 0.8×	998 1.3×	437 0.8×	219	5.0k
Clive Harmer United Kingdom	42	1.7k 1.0×	1.2k 0.8×	1.2k 1.2×	285 0.4×	164 0.3×	138	4.9k
L. Weißbach Germany	27	2.2k 1.2×	1.7k 1.1×	397 0.4×	786 1.0×	430 0.7×	232	3.7k
Jean‐Michel Zucker France	32	652 0.4×	1.5k 0.9×	775 0.8×	813 1.1×	971 1.7×	77	3.7k
H. Schraffordt Koops Netherlands	31	1.6k 0.9×	1.0k 0.6×	799 0.8×	714 1.0×	360 0.6×	113	3.0k
Alexandra W. van den Belt‐Dusebout Netherlands	17	710 0.4×	734 0.5×	729 0.7×	365 0.5×	359 0.6×	27	3.2k
Cynthia E. Herzog United States	32	625 0.4×	1.1k 0.7×	1.0k 1.0×	617 0.8×	366 0.6×	91	2.7k

Countries citing papers authored by Vaia Vlamis

Since Specialization

Citations

This map shows the geographic impact of Vaia Vlamis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vaia Vlamis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vaia Vlamis more than expected).

Fields of papers citing papers by Vaia Vlamis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vaia Vlamis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vaia Vlamis. The network helps show where Vaia Vlamis may publish in the future.

Co-authorship network of co-authors of Vaia Vlamis

This figure shows the co-authorship network connecting the top 25 collaborators of Vaia Vlamis. A scholar is included among the top collaborators of Vaia Vlamis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vaia Vlamis. Vaia Vlamis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bajorin, Dean F., Madhu Mazumdar, Michael L. Meyers, et al.. (1998). Metastatic germ cell tumors: modeling for response to chemotherapy.. Journal of Clinical Oncology. 16(2). 707–715. 21 indexed citations

Newman, Kurt D., Glenn Heller, Richard G. Azizkhan, et al.. (1998). Differentiated Thyroid Cancer: Determinants of Disease Progression in Patients <21 Years of Age at Diagnosis. Annals of Surgery. 227(4). 533–541. 160 indexed citations

Xiao, Han, Madhu Mazumdar, Dean F. Bajorin, et al.. (1997). Long-term follow-up of patients with good-risk germ cell tumors treated with etoposide and cisplatin.. Journal of Clinical Oncology. 15(7). 2553–2558. 43 indexed citations

Motzer, Robert J., Madhu Mazumdar, Dean F. Bajorin, et al.. (1997). High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors.. Journal of Clinical Oncology. 15(7). 2546–2552. 112 indexed citations

Berg, William J., Lawrence H. Schwartz, Alison Amsterdam, et al.. (1997). A Phase II study of 13-cis-retinoic acid in patients with advanced renal cell carcinoma. Investigational New Drugs. 15(4). 353–355. 27 indexed citations

Balmaceda, Casilda, Gordon Heller, Marc K. Rosenblum, et al.. (1996). Chemotherapy without irradiation--a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study.. Journal of Clinical Oncology. 14(11). 2908–2915. 258 indexed citations

Steineck, Gunnar, William Kevin Kelly, Madhu Mazumdar, et al.. (1996). Acid phosphatase: defining a role in androgen-independent prostate cancer. Urology. 47(5). 719–726. 13 indexed citations

Motzer, Robert J., Joel Sheinfeld, Madhu Mazumdar, et al.. (1995). Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumors.. Journal of Clinical Oncology. 13(11). 2700–2704. 49 indexed citations

Motzer, Robert J., Lawrence B. Schwartz, Teresa Murray Law, et al.. (1995). Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro.. Journal of Clinical Oncology. 13(8). 1950–1957. 116 indexed citations

10.

Vaccarello, Luis, Stephen C. Rubin, Vaia Vlamis, et al.. (1995). Cytoreductive Surgery in Ovarian Carcinoma Patients with a Documented Previously Complete Surgical Response. Gynecologic Oncology. 57(1). 61–65. 109 indexed citations

11.

Law, Teresa Murray, Robert J. Motzer, Madhu Mazumdar, et al.. (1995). Phase iii randomized trial of interleukin-2 with or without lymphokine-activated killer cells in the treatment of patients with advanced renal cell carcinoma. Cancer. 76(5). 824–832. 201 indexed citations

12.

Kornblith, Alice B., Howard T. Thaler, George Y. Wong, et al.. (1995). Quality of Life of Women with Ovarian Cancer. Gynecologic Oncology. 59(2). 231–242. 125 indexed citations

13.

Murphy, Barbara A., Robert J. Motzer, Madhu Mazumdar, et al.. (1994). Serum tumor marker decline is an early predictor of treatment outcome in germ cell tumor patients treated with cisplatin and ifosfamide salvage chemotherapy. Cancer. 73(10). 2520–2526. 42 indexed citations

14.

Mencel, Peter, Robert J. Motzer, Madhu Mazumdar, et al.. (1994). Advanced seminoma: treatment results, survival, and prognostic factors in 142 patients.. Journal of Clinical Oncology. 12(1). 120–126. 101 indexed citations

15.

Barakat, Richard R., et al.. (1994). Tamoxifen Use in Breast Cancer Patients Who Subsequently Develop Corpus Cancer Is Not Associated with a Higher Incidence of Adverse Histologic Features. Gynecologic Oncology. 55(2). 164–168. 119 indexed citations

16.

LaQuaglia, Michael P., Glenn Heller, Fereshteh Ghavimi, et al.. (1994). The effect of age at diagnosis on outcome in rhabdomyosarcoma. Cancer. 73(1). 109–117. 88 indexed citations

17.

Motzer, Robert J., Madhu Mazumdar, Subhash C. Gulati, et al.. (1993). Phase II Trial of High-Dose Carboplatin and Etoposide With Autologous Bone Marrow Transplantation in First-Line Therapy for Patients With Poor-Risk Germ Cell Tumors. JNCI Journal of the National Cancer Institute. 85(22). 1828–1835. 112 indexed citations

18.

Minasian, Lori M., Robert J. Motzer, Louis Gluck, et al.. (1993). Interferon alfa-2a in advanced renal cell carcinoma: treatment results and survival in 159 patients with long-term follow-up.. Journal of Clinical Oncology. 11(7). 1368–1375. 224 indexed citations

19.

Nanus, David M., Bernd J. Schmitz‐Dräger, Robert J. Motzer, et al.. (1993). Expression of Basic Fibroblast Growth Factor in Primary Human Renal Tumors: Correlation With Poor Survival. JNCI Journal of the National Cancer Institute. 85(19). 1597–1599. 99 indexed citations

20.

LaQuaglia, Michael P., Glenn Heller, Vaia Vlamis, et al.. (1992). Prognostic factors and outcome in patients 21 years and under with colorectal carcinoma. Journal of Pediatric Surgery. 27(8). 1085–1090. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact